30.49
price up icon1.33%   0.40
after-market After Hours: 30.49
loading
Vera Therapeutics Inc stock is traded at $30.49, with a volume of 788.92K. It is up +1.33% in the last 24 hours and up +28.27% over the past month. Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$30.09
Open:
$30.42
24h Volume:
788.92K
Relative Volume:
0.54
Market Cap:
$1.95B
Revenue:
-
Net Income/Loss:
$-107.85M
P/E Ratio:
-13.80
EPS:
-2.21
Net Cash Flow:
$-106.82M
1W Performance:
-1.45%
1M Performance:
+28.27%
6M Performance:
+35.93%
1Y Performance:
-28.63%
1-Day Range:
Value
$29.72
$30.85
1-Week Range:
Value
$29.41
$31.80
52-Week Range:
Value
$18.53
$51.61

Vera Therapeutics Inc Stock (VERA) Company Profile

Name
Name
Vera Therapeutics Inc
Name
Phone
650-770-0077
Name
Address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Name
Employee
192
Name
Twitter
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
VERA's Discussions on Twitter

Compare VERA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VERA
Vera Therapeutics Inc
30.49 1.92B 0 -107.85M -106.82M -2.21
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-04-25 Downgrade Wolfe Research Outperform → Peer Perform
May-05-25 Resumed H.C. Wainwright Buy
Feb-04-25 Initiated Wolfe Research Outperform
Jan-28-25 Initiated Goldman Buy
Nov-21-24 Initiated Wells Fargo Overweight
Oct-16-24 Initiated Scotiabank Sector Outperform
Jan-25-24 Initiated Oppenheimer Outperform
Jan-08-24 Initiated Cantor Fitzgerald Overweight
Dec-18-23 Initiated Raymond James Outperform
Nov-10-23 Upgrade Jefferies Hold → Buy
Aug-16-23 Initiated Guggenheim Buy
Jan-04-23 Downgrade Jefferies Buy → Hold
Jan-04-23 Downgrade Wedbush Outperform → Neutral
Jul-12-22 Initiated JP Morgan Overweight
May-02-22 Initiated H.C. Wainwright Buy
Apr-19-22 Initiated Wedbush Outperform
View All

Vera Therapeutics Inc Stock (VERA) Latest News

pulisher
11:17 AM

Can Vera Therapeutics Inc. hit a new high this monthBond Market & Consistent Profit Trade Alerts - newser.com

11:17 AM
pulisher
10:43 AM

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener

10:43 AM
pulisher
10:07 AM

Ranking Vera Therapeutics Inc. among high performing stocks via toolsTrade Entry Summary & Weekly Watchlist of Top Performers - newser.com

10:07 AM
pulisher
05:26 AM

Is Vera Therapeutics Inc. stock overvalued by current metricsJuly 2025 Levels & Reliable Breakout Forecasts - newser.com

05:26 AM
pulisher
04:21 AM

Vera Therapeutics Inc. stock trend forecastCPI Data & High Return Stock Watch Alerts - newser.com

04:21 AM
pulisher
02:17 AM

Is Vera Therapeutics Inc a good long term investmentBear Market Strategies & Follow Top Performers in the Community - earlytimes.in

02:17 AM
pulisher
Oct 12, 2025

Why Vera Therapeutics Inc. stock could rally in 2025Portfolio Return Report & Accurate Buy Signal Notifications - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Vera started at buy by Goldman Sachs, atacicept potential cited - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 10, 2025
pulisher
Oct 10, 2025

Trend analysis for Vera Therapeutics Inc. this weekTrade Risk Report & Community Consensus Stock Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Detecting support and resistance levels for Vera Therapeutics Inc.2025 Dividend Review & Fast Entry Momentum Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Vera Therapeutics' (VERA) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Polycythemia Vera Pipeline 2025: FDA Updates, Therapy - openPR.com

Oct 09, 2025
pulisher
Oct 09, 2025

What indicators show strength in Vera Therapeutics Inc.Portfolio Gains Summary & Technical Pattern Alert System - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Using RSI to spot recovery in Vera Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Heatmap analysis for Vera Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Vera Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Risk vs reward if holding onto Vera Therapeutics Inc.2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

J. Safra Sarasin Holding AG Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat

Oct 05, 2025
pulisher
Oct 03, 2025

Evaluating Vera Therapeutics Inc. with trendline analysisJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Developing predictive dashboards with Vera Therapeutics Inc. dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

What drives Vera Therapeutics Inc stock priceLong-Term Growth Stocks & These Stocks Are Just Getting Started - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛

Oct 02, 2025
pulisher
Oct 02, 2025

Vera Therapeutics, Inc. $VERA Shares Purchased by Platinum Investment Management Ltd. - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

13,567 Shares in Vera Therapeutics, Inc. $VERA Acquired by GC Wealth Management RIA LLC - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Fifth Third Bancorp Buys New Stake in Vera Therapeutics, Inc. $VERA - Defense World

Oct 02, 2025
pulisher
Oct 01, 2025

10,406 Shares in Vera Therapeutics, Inc. $VERA Purchased by Perigon Wealth Management LLC - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating - 富途牛牛

Sep 30, 2025
pulisher
Sep 29, 2025

What analysts say about Vera Therapeutics Inc stockDividend Reinvestment Plans & Low Risk Investment Tips - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

Vera Therapeutics Inc Stock Analysis and ForecastHigh Beta Stocks & Small Entry Investment Ideas - Early Times

Sep 28, 2025
pulisher
Sep 28, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Sep 28, 2025
pulisher
Sep 25, 2025

Vera Therapeutics (NASDAQ:VERA) Shares Up 5.3%Time to Buy? - MarketBeat

Sep 25, 2025
pulisher
Sep 24, 2025

Vera Therapeutics (VERA): Assessing Valuation After New KDIGO Guidelines Shape the IgA Nephropathy Market - Sahm

Sep 24, 2025

Vera Therapeutics Inc Stock (VERA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Vera Therapeutics Inc Stock (VERA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
ENRIGHT PATRICK G
Director
Jun 24 '25
Buy
22.35
40,607
907,635
3,596,593
Fordyce Marshall
PRESIDENT AND CEO
Feb 21 '25
Sale
27.89
10,613
296,032
213,740
Fordyce Marshall
PRESIDENT AND CEO
Feb 26 '25
Sale
27.65
9,075
250,882
204,665
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):